0001415889-24-017632.txt : 20240620
0001415889-24-017632.hdr.sgml : 20240620
20240620162241
ACCESSION NUMBER: 0001415889-24-017632
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240618
FILED AS OF DATE: 20240620
DATE AS OF CHANGE: 20240620
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shafer Christina
CENTRAL INDEX KEY: 0001934412
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36576
FILM NUMBER: 241056564
MAIL ADDRESS:
STREET 1: 5 RADNOR CORPORATE CENTER, SUITE 500
STREET 2: 100 MATSONFORD ROAD
CITY: RADNOR
STATE: PA
ZIP: 19087
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MARINUS PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001267813
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 RADNOR CORPORATE CENTER SUITE 500
STREET 2: 100 MATSONFORD RD
CITY: RADNOR
STATE: PA
ZIP: 19087
BUSINESS PHONE: 484-801-4670
MAIL ADDRESS:
STREET 1: 5 RADNOR CORPORATE CENTER SUITE 500
STREET 2: 100 MATSONFORD RD
CITY: RADNOR
STATE: PA
ZIP: 19087
FORMER COMPANY:
FORMER CONFORMED NAME: MARINUS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20031022
4
1
form4-06202024_080637.xml
X0508
4
2024-06-18
0001267813
MARINUS PHARMACEUTICALS, INC.
MRNS
0001934412
Shafer Christina
5 RADNOR CORPORATE CENTER, SUITE 500
100 MATSONFORD RD
RADNOR
PA
19087
false
true
false
false
CHIEF COMMERCIAL OFFICER
0
Common Stock
2024-06-18
4
A
0
10918
0
A
71226
D
Stock Option (Right to Buy)
1.40
2024-06-18
4
A
0
49125
0
A
2034-06-18
Common Stock
49125
49125
D
Represents the grant of restricted stock units (RSUs). The RSUs vest in full on July 15, 2025, subject to the reporting person's continued service with Marinus Pharmaceuticals, Inc. (the Issuer). Each RSU represents the right to receive one share of common stock of the Issuer.
The option vests and becomes exercisable in full on July 15, 2025, subject to the reporting person's continued service with the Issuer.
/s/ Debra A. Mohollen, Attorney-in-Fact
2024-06-20